Akero Looks To Accelerate Path To Pivotal NASH Data With Phase IIb/III Protocol

89Bio Builds Case For Safety Advantage As FGF Competition Heats Up

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.